Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.

Biotechnology

Angiocrine Bioscience

Angiocrine Bioscience's headquarters in San Diego, CA, United States

Paul Finnegan

John K. Fraser

John Lomoro

Geoff Davis

John R. Jaskowiak

David R. Parkinson

Jason M. Butler

Hans-Peter Kiem

Jeffrey L. Port

Lee M. Ellis

Robert S. Kerbel

David Cheresh

Shahin Rafii

James Garmendia

The Executive Administration team at Angiocrine Bioscience plays a pivotal role in strategic leadership and operational oversight. Comprised of top executives including the CEO, COO, CFO, and other key leaders, the team collaborates to drive the company's vision, streamline decision-making processes, and ensure effective governance to advance innovative therapies that improve patient outcomes.

Executive Administration

The Leadership Team at Angiocrine Bioscience drives the company's strategic vision and operational execution, overseeing key areas such as scientific innovation, financial management, and organizational effectiveness. Comprised of experienced professionals in cell and gene therapy, the team collaborates to advance research initiatives, secure funding, and guide clinical development, all aimed at delivering transformative therapies for patients with serious medical conditions.

Leadership Team

The Advisory Team at Angiocrine Bioscience provides strategic guidance and expertise to advance the company’s clinical programs and therapeutic approaches. Comprised of seasoned professionals from diverse backgrounds in medicine, research, and industry, the team collaborates to ensure effective decision-making and alignment with best practices in cell and gene therapy, ultimately enhancing the company's mission to revolutionize patient care through innovative treatments.

Advisory Team

The Research and Development team at Angiocrine Bioscience is dedicated to advancing innovative cell and gene therapies by designing and conducting experiments to evaluate the efficacy and safety of genetically modified endothelial cells. This multidisciplinary team collaborates on product development, external research partnerships, and bioprocess engineering, ensuring the successful translation of scientific discoveries into clinical applications to improve patient outcomes.

Research and Development

The Clinical Development Team at Angiocrine Bioscience is responsible for designing and overseeing clinical trials to evaluate the safety and effectiveness of innovative cell and gene therapies. This team collaborates closely with pre-clinical, project management, and technical operations to ensure seamless execution of clinical protocols, data integrity, and compliance with regulatory standards, ultimately aiming to bring groundbreaking treatments to patients with serious medical conditions.

Angiocrine Bioscience

Org chart

Board & advisors

Teams

Executive Administration

Leadership Team

Advisory Team

Research and Development

Clinical Development Team

Offices

Angiocrine Bioscience

Org chart

Board & advisors

Teams

Executive Administration

Leadership Team

Advisory Team

Research and Development

Clinical Development Team

Offices

Related companies